South Africa plans to produce lenacapavir, an anti-HIV jab, on home soil amid a funding crisis, led by Thembi Xulu, CEO of National Aids Council.

South Africa could get an HIV prevention pill years early through a unique licensing deal, accelerating access to life-saving treatment.

South Africa's infant mortality rates exceed UN targets, with 29 newborn deaths daily in 2024. Learn why maternal and neonatal deaths are rising.

South Africa advances local HIV drug production with lenacapavir, led by Sanac CEO Thembi Xulu at the International Aids Conference.

HIV epidemic targets depend on trust, mental health, and communities to end the epidemic successfully.

Learn why social media platforms block user accounts and how to address blocking issues effectively.

Cancer treatment in India drains livelihoods, leaving patients jobless and struggling with costly therapies despite improving survival rates.

Global health agencies face a funding crisis, shifting focus to self-reliance strategies. Explore vital signs in global health developments and funding challeng

Unitaid's private leadership search sparks transparency concerns amid funding declines and calls for global health reform.

Africa must reframe air pollution as a financial risk to secure funding for cleaner air and save lives.